Lead optimization of the 5-phenylpyrazolopyrimidinone NPD-2975 toward compounds with improved antitrypanosomal efficacy
Bron
Journal of medicinal chemistry - ISSN 0022-2623-67:4 (2024) p. 2849-2863
DNDI-6174 is a preclinical candidate for visceral leishmaniasis that targets the cytochrome bc₁
Bron
Science translational medicine - ISSN 1946-6234-15:726 (2023) p.
Discovery of 5-phenylpyrazolopyrimidinone analogs as potent antitrypanosomal agents with in vivo efficacy
Bron
Journal of medicinal chemistry - ISSN 0022-2623-66:15 (2023) p. 10252-10264
Structural optimization of BIPPO analogs as potent antimalarials
Bron
Molecules: a journal of synthetic chemistry and natural product chemistry - ISSN 1420-3049-28:13 (2023) p. 1-16
To target or not to target Schistosoma mansoni cyclic nucleotide phosphodiesterase 4A?
Bron
International journal of molecular sciences - ISSN 1422-0067-24:7 (2023) p. 1-18